Trademark: 87269712
Status Date
Tuesday, February 11, 2020
Registration Number
5984748
Registration Date
Tuesday, February 11, 2020
Filing Date
Thursday, December 15, 2016
Published for Opposition
Tuesday, September 4, 2018
5 Medical preparations, namely, solutions containing platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations contain, in addition to platelets, mesenchymal and other stem and progenitor cells, for use on, in, or under tissue, bone and organs for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone and periodontum growth and bone, organ or tissue regeneration
10 Kits comprising at least one receptacle for receipt and separation of blood components from each other used to prepare platelet rich plasma, derived from donors pre-treated with g-csf, such that said platelet rich plasma features mesenchymal and other stem and progenitor cells in addition to platelets
35 Marketing services in the nature of marketing and business support services for physicians who provide clinical medical practice consultation services in the field of advanced regenerative technologies featuring provision of preparations or services comprising application on, in, or under tissue, bone or organs of platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations contain, in addition to platelets, mesenchymal and other stem and progenitor cells, for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontal growth and bone organ or tissue regeneration
41 Educational services, namely, providing clinical training in the field of advanced regenerative technologies, namely, training for physicians to perform clinical services in the field of advanced regenerative technologies; providing training to prepare and provide preparations or services comprising application on, in, or under tissue, bone or organs of platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations contain, in addition to platelets, mesenchymal and other stem and progenitor cells, for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontal growth and bone organ or tissue regeneration
44 Medical, veterinary, hygienic and beauty care services for human beings or animals, namely, the preparation, provision or both in or under tissue, bone or organs, of platelet rich plasma derived from donors pre-treated with G-CSF such that said preparations contain, in addition to platelets, mesenchymal and other stem and progenitor cells, for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontal growth and bone organ or tissue regeneration
Jan 4, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 4, 2022
Teas Change Of Correspondence Received
Jan 4, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 4, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 4, 2022
Teas Change Of Owner Address Received
Feb 11, 2020
Registered-Principal Register
Jan 4, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Jan 3, 2020
Allowed Principal Register - Sou Accepted
Dec 14, 2019
Teas/Email Correspondence Entered
Dec 13, 2019
Correspondence Received In Law Office
Dec 13, 2019
Teas Response To Office Action Received
Jun 13, 2019
Notification Of Non-Final Action E-Mailed
Jun 13, 2019
Non-Final Action E-Mailed
Jun 13, 2019
Su - Non-Final Action - Written
May 31, 2019
Assigned To Examiner
Apr 24, 2019
Statement Of Use Processing Complete
Apr 12, 2019
Use Amendment Filed
Apr 24, 2019
Case Assigned To Intent To Use Paralegal
Apr 12, 2019
Teas Statement Of Use Received
Mar 28, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 28, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 30, 2018
Noa E-Mailed - Sou Required From Applicant
Sep 4, 2018
Official Gazette Publication Confirmation E-Mailed
Sep 4, 2018
Published For Opposition
Aug 15, 2018
Notification Of Notice Of Publication E-Mailed
Jul 30, 2018
Law Office Publication Review Completed
Jul 20, 2018
Assigned To Lie
Jul 19, 2018
Approved For Pub - Principal Register
Jul 6, 2018
Examiner's Amendment Entered
Jul 6, 2018
Notification Of Examiners Amendment E-Mailed
Jul 6, 2018
Examiners Amendment E-Mailed
Jul 6, 2018
Examiners Amendment -Written
Jun 19, 2018
Previous Allowance Count Withdrawn
May 15, 2018
Withdrawn From Pub - Og Review Query
Apr 27, 2018
Approved For Pub - Principal Register
Apr 19, 2018
Teas/Email Correspondence Entered
Apr 19, 2018
Correspondence Received In Law Office
Apr 19, 2018
Teas Request For Reconsideration Received
Apr 19, 2018
Notification Of Final Refusal Emailed
Apr 19, 2018
Final Refusal E-Mailed
Apr 19, 2018
Final Refusal Written
Mar 7, 2018
Teas/Email Correspondence Entered
Mar 7, 2018
Correspondence Received In Law Office
Feb 28, 2018
Assigned To Lie
Feb 19, 2018
Notice Of Revival - E-Mailed
Feb 18, 2018
Teas Response To Office Action Received
Feb 18, 2018
Petition To Revive-Granted
Feb 18, 2018
Teas Petition To Revive Received
Feb 18, 2018
Teas Change Of Correspondence Received
Feb 9, 2018
Abandonment Notice Mailed - Failure To Respond
Feb 9, 2018
Abandonment - Failure To Respond Or Late Response
Jul 12, 2017
Notification Of Priority Action E-Mailed
Jul 12, 2017
Priority Action E-Mailed
Jul 12, 2017
Priority Action Written
Apr 7, 2017
Teas/Email Correspondence Entered
Apr 7, 2017
Correspondence Received In Law Office
Apr 7, 2017
Teas Response To Office Action Received
Mar 31, 2017
Notification Of Non-Final Action E-Mailed
Mar 31, 2017
Non-Final Action E-Mailed
Mar 31, 2017
Non-Final Action Written
Mar 17, 2017
Assigned To Examiner
Dec 21, 2016
New Application Office Supplied Data Entered In Tram
Dec 19, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
